Abstract
692P - Identification of an RNF43 mutated gastric cancer patient population with potential sensitivity to porcupine inhibitor RXC004 and development of a complimentary ctDNA liquid biopsy assay for patient screening
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have